Kerosene poisoning in children: a report from northern Jordan

F Abu-Ekteish1

  • 1Department of Paediatrics, Jordan University of Science and Technology, Irbid. faisall152@yahoo.com

Tropical Doctor
|May 7, 2002
PubMed

Insights

Kerosene ingestion in children is a significant risk, especially for those under 4 years old. Prompt medical care and preventive measures are crucial for recovery from this common household poisoning.

Area of Science:

  • Pediatrics
  • Toxicology
  • Public Health

Background:

  • Kerosene ingestion is a prevalent cause of childhood poisoning.
  • Understanding risk factors and clinical presentation is vital for effective management.

Purpose of the Study:

  • To evaluate children with kerosene ingestion in northern Jordan.
  • To identify common demographics, symptoms, storage practices, and outcomes.

Main Methods:

  • Prospective study over 4 years.
  • Inclusion of 120 children aged 11 months to 6 years.
  • Data collection on symptoms, storage, and treatment outcomes.

Main Results:

  • Majority of patients (90%) were under 4 years old.
  • Common symptoms included cough (70.6%), tachypnea (59.6%), and fever (55.1%).
  • Kerosene was often stored in soft drink bottles in kitchens and under stairs.

Conclusions:

  • Kerosene ingestion poses a significant risk to young children.
  • Symptomatic treatment leads to near-complete recovery.
  • Health education and preventive strategies are essential.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...